Latest Articles
Adjuvant Chemotherapy Improves Long-Term Survival in Endometrial Cancer - CancerNetwork
Adjuvant Chemotherapy Improves Long-Term Survival in Endometrial Cancer CancerNetwork
Published: Oct. 13, 2025, 10:05 p.m.
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors - Medpage Today
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors Medpage Today
Published: Dec. 18, 2024, 8:16 p.m.
Link copied to clipboard!